Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tranexamic acid during cesarean section: impact on bleeding, infection and recovery
2018-003960-29Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tranexamic acid in cesarean delivery complication and thromboembolism, sponsored by Turku University Hospital. Primary endpoint: Operative complications (bleeding). Started Oct 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
cesarean delivery complicationthromboembolism
Beyond the preview
Go deeper on 2018-003960-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003960-29.